Clinical Trial Update: A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SCG101 TCR-T Cell Therapy for hepatitis B virus–related hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SCG101 TCR-T Cell Therapy (SCG101 TCR-T cell therapy)

Snippet

Sponsor: SCG Cell Therapy Pte. Ltd. | Conditions: HCC, Hepatitis B Virus Related Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING